Company: LENZ
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001815776-25-000019
Chunk: 194

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 12
Chunk 194
---
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 

The following table sets forth information regarding the beneficial ownership of Common Stock as of March 12, 2025 by:

•each person known by us to be the beneficial owner of more than 5% of our outstanding Common Stock;

•each of our named executive officers and our directors; and

•all of our executive officers and directors as a group.

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security. Under those rules, beneficial ownership includes securities that the individual or entity has the right to acquire, such as through the exercise of stock options, within 60 days of March 12, 2025. Shares subject to options that are currently exercisable or exercisable within 60 days of March 12, 2025 are considered outstanding and beneficially owned by the person holding such options for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. Except as noted by footnote, and subject to community property laws where applicable, based on the information provided to us, we believe that the persons and entities named in the table below have sole voting and investment power with respect to all shares shown as beneficially owned by them. Unless otherwise noted, the business address of each of the Company's directors and executive officers is 201 Lomas Santa Fe Drive Suite 300, Solana Beach, California 92075. The percentage of beneficial ownership of LENZ Therapeutics, Inc. is calculated based on 27,542,874 shares of Common Stock outstanding as of March 12, 2025.

154

Table of Contents

Name of Beneficial OwnersNumber of Shares%Greater than 5% StockholdersAlpha Wave Ventures II, LP(1)3,612,211 13.1 %Entities affiliated with Point72 Asset Management(2)1,882,693 6.8 %Entities affiliated with RA Capital Management(3)4,259,106 15.5 %Entities affiliated with Versant Management(4)4,612,684 16.7 %Ridgeback Capital Investments L.P.(5)1,951,875 7.1 %Executive Officers and DirectorsEvert Schimmelpennink(6)769,